Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Scientific & Clinical Review of Minimal Stimulation Protocol Using AROMEK (Letrozole) and Follitrope (Recombinant FSH)Combined With INVOCell(Intravaginal Culturing) - Effectiveness as Low Cost IVF

NCT01058252 is registered in ClinicalTrials.gov with Galaxy Pharma (Pvt) Limited as lead sponsor.

NCT NCT01058252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01058252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Scientific & Clinical Review of Minimal Stimulation Protocol Using AROMEK (Letrozole) and Follitrope (Recombinant FSH)Combined With INVOCell(Intravaginal Culturing) - Effectiveness as Low Cost IVF
Lead sponsor
Galaxy Pharma (Pvt) Limited
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2021
Completion date
March 31, 2022
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

low responders, mild to moderate male factor infertility, primary infertility, secondary infertility